HSDTNASDAQHealthcare

Public company intelligence preview

SOLANA CO

18 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
18
2 filed in the last 30 days
Acquisition / disposition count
17/1
Buy / Sell
Unique insiders active in the last year
8
Current insider positions tracked
15
14 active, 1 exited

Insider compensation

Public aggregate: $1.2M average total compensation across covered insiders.

Governance movement

Public aggregate: 6 governance events in the last year.

Institutional ownership

Public aggregate: 43 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
0
Restricted-sale insiders, 1Y
0
Planned sale shares, 1Y
0
Planned sale value, 1Y
$0.00
Insiders covered
7
Latest year: 2025
Personnel changes, 1Y
5
Board appointments, 1Y
3
Board departures, 1Y
3

Market context

Basic quote context for the preview.

Price
$1.91
Market cap
$111.2M
Volume
333,392
EPS
$-1.30
Revenue
$3.6M
Employees
21

Company note

Context before the data.

Company Overview

Solana Company (NASDAQ: HSDT) is in the Healthcare sector and Medical Devices industry, but its business has undergone a major pivot into a digital asset treasury model centered on Solana (SOL). The company’s stated goal is to maximize SOL per share through treasury management, open-market purchases, staking, and other capital markets activities, while still maintaining a smaller neurotechnology business built around the PoNS Therapy system. The PoNS business remains focused on a non-implantable device used with supervised therapeutic exercise for gait and balance deficits, with regulatory clearances in the U.S., Canada, and Australia and a pending FDA label expansion for stroke. This unusual mix of a crypto treasury and a legacy medical device operation makes the company highly sensitive to both SOL market dynamics and medical device commercialization/regulatory progress.

Executive Compensation Practices

For companies in the Healthcare / Medical Devices space, executive pay often includes a mix of salary, annual bonus, equity awards, and performance incentives tied to commercialization milestones, regulatory approvals, revenue growth, and cost control. For Solana Company specifically, compensation drivers are likely to be influenced more heavily by the success of the digital asset treasury strategy than by traditional device metrics, especially given the company’s emphasis on increasing net asset value, staking yields, financing execution, and balance-sheet growth in SOL. The filings show meaningful non-cash stock compensation and even a discretionary bonus, suggesting a compensation structure that can still reward management for strategic execution during a transition period. Because reported results are dominated by fair-value accounting, derivative liabilities, and crypto price swings, investors should pay close attention to whether executive incentives are aligned with shareholder dilution, SOL accumulation, staking income, and operational discipline rather than short-term accounting gains.

Insider Trading Considerations

Insider trading patterns at Solana Company may be especially important because the stock’s value is likely to react to both SOL price moves and company-specific treasury actions such as financing rounds, staking changes, custodial developments, and asset sales. Executives and directors may have heightened awareness of nonpublic information about the company’s SOL holdings, staking rewards, financing needs, and regulatory exposure, all of which can materially affect valuation. In the Medical Devices industry, insider activity can also reflect expectations around FDA review, reimbursement progress, and PoNS sales momentum, but at this company those factors may be secondary to crypto-related catalysts. Researchers and traders should watch for transactions around PIPE financings, warrant exercises, treasury disclosures, and SOL price volatility, since these events can create unusual insider trading windows and potentially large informational advantages.

Unlock the full HSDT insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.